CDK4/6 inhibitors in advanced breast cancer, what is beyond?
Saved in:
| Title: | CDK4/6 inhibitors in advanced breast cancer, what is beyond? |
|---|---|
| Authors: | Mohammed AA; Medical Oncology Department, Faculty of Medicine, Zagazig University, Egypt.; King Salman Armed Forces Hospital, Tabuk City, KSA., Rashied H; El-mabra Hospital, Zagazig, Egypt., Elsayed FM; Clinical Oncology & Nuclear Medicine, Department Faculty of Medicine Suez Canal University, Egypt. |
| Source: | Oncology reviews [Oncol Rev] 2019 Jul 29; Vol. 13 (2), pp. 416. Date of Electronic Publication: 2019 Jul 29 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 101519906 Publication Model: eCollection Cited Medium: Print ISSN: 1970-5565 (Print) Linking ISSN: 19705557 NLM ISO Abbreviation: Oncol Rev Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
